!! Big Boards scans, charts and news !!

[dDT]

January 2013 FDA plays

>>> Link back for December plays (Check ibox for more)

01/10/2013 Johnson & Johnson JNJ Canagliflozin (NDA) (Trade name INVOKANA)

FDA panel to review INVOKANA for type 2 diabetes




01/16/2013 Santarus Inc. SNTS UCERIS (NDA)

FDA decision on UCERIS for induction of remission of mild to moderate active ulcerative colitis




01/17/2013 NuPathe Inc. PATH Zecuity (formerly known as NP101 and Zelrix) (NDA resubmission)

FDA decision on Zecuity for treatment of migraine




01/21/2013 Impax Laboratories Inc IPXL IPX066 or Rytary (NDA)

FDA decision on Rytary for treatment of idiopathic Parkinson's disease




01/23/2013 Hyperion Therapeutics, Inc. HPTX Ravicti (NDA)

FDA decision on Ravicti for treatment of urea cycle disorder




01/29/2013 ISIS Pharmaceuticals Inc ISIS KYNAMRO (NDA)

FDA decision on KYNAMRO for treatment of patients with homozygous familial hypercholesterolemia




01/30/2013 Raptor Pharmaceuticals Corp. RPTP RP103 (NDA)

FDA decision on RP103 for potential treatment of nephropathic cystinosis FDA extends decision date to Apr.30, 2013